ARCHIVES

Research teams link response to Iressa to mutations in EGF receptor.

This article is from The Cancer Letter archive.

Vol. 30 No. 18 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

FASEB urges 10 percent increase for NIH in FY 2005.

January 23, 2004

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

June 9, 2006

NCI to Undergo More GAO Probes

July 15, 1977

Colorado Governor Signs Bill Mandating Reimbursement For Mammography Screening

April 21, 1989

Postoperative Chemo Doesn’t Improve Survival, Study Finds

March 28, 2008

Harold Freeman To Direct NCI Center To Reduce Cancer Health Disparities.

September 15, 2000